Large stock awards and trust transfer for Cinemark (NYSE: CNK) EVP

Rhea-AI Filing Summary

Cinemark Holdings EVP-General Counsel Michael Cavalier reported several equity award and related share-disposition transactions in Cinemark common stock. On February 20, 2026, he received 107,876 shares from vesting performance stock units and 20,275 restricted shares, with multiple blocks of shares withheld to cover tax liabilities at prices around $26.36 per share.

On February 21, 2026, additional shares were withheld for taxes at $26.49 per share, and 82,052 shares were transferred for no consideration to the Cavalier Revocable Trust, where he and his spouse are co-trustees and his family are beneficiaries, so he remains a beneficial owner of those trust-held shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cavalier Michael

(Last) (First) (Middle)

3900 DALLAS PARKWAY

(Street)

PLANO TX 75093

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cinemark Holdings, Inc. [ CNK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP-General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		107,876(1)	A	$26.36	157,638	D
Common Stock	02/20/2026		F		42,665(2)	D	$26.36	114,973	D
Common Stock	02/20/2026		F		4,717(3)	D	$26.36	110,256	D
Common Stock	02/20/2026		F		3,761(4)	D	$26.36	106,495	D
Common Stock	02/20/2026		A		20,275	A	$0(5)	126,770	D
Common Stock	02/21/2026		F		2,445(6)	D	$26.49	124,325	D
Common Stock	02/21/2026		G		82,052	D	$0	42,273	D(7)
Common Stock								330,681	I(7)	Cavalier Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported shares are the vesting of performance stock units issued in February 2023 at maximum.

2. The reported shares were withheld by the issuer as payment by the reporting person for the tax liability upon vesting of 107,876 performance shares granted on February 20, 2023 referred to in footnote 1.

3. The reported shares were withheld by the issuer as payment by the reporting person for the tax liability upon vesting of 11,989 which is a portion of the restricted stock granted on February 20, 2023.

4. The reported shares were withheld by the issuer as payment by the reporting person for the tax liability upon vesting of 9,559 which is a portion of the restricted stock which was granted on February 20, 2024.

5. Restricted shares were issued in consideration for future services and vest ratably over a 3-year period.

6. The reported shares were withheld by the issuer as payment by the reporting person for the tax liability upon vesting of 6,216 which is a portion of restricted stock which was granted on February 21, 2025.

7. On February 21, 2026, the reporting person transferred 82,052 shares to the Cavalier Revocable Trust for no consideration. The reporting person and his spouse are co-trustees of the Cavalier Revocable Trust and the reporting person and members of his immediate family are the sole beneficiaries of the trust. The reporting person remains a beneficial owner of the securities held by the trust.

	/s/ Michael Cavalier attorney-in-fact	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Cinemark (CNK) executive Michael Cavalier report on this Form 4?

Michael Cavalier reported equity awards, tax-withholding dispositions, and a trust transfer. He received performance and restricted stock, had several share blocks withheld to cover taxes, and moved 82,052 shares into a revocable trust while retaining beneficial ownership through his trustee role and family beneficiary status.

How many Cinemark (CNK) shares did Michael Cavalier acquire through awards in February 2026?

Cavalier acquired 128,151 Cinemark common shares through equity awards. This includes 107,876 shares from vesting performance stock units and 20,275 restricted shares issued in consideration for future services, which are scheduled to vest ratably over a three-year period according to the filing footnotes.

What were the tax-withholding share dispositions reported for Cinemark (CNK) stock?

Several share blocks were withheld to satisfy tax liabilities on vesting awards. On February 20 and 21, 2026, Cinemark withheld multiple lots of common stock at prices near $26.36–$26.49 per share as payment for Cavalier’s tax obligations upon vesting of performance and restricted stock awards.

What is the significance of the 82,052-share transfer to the Cavalier Revocable Trust for CNK?

82,052 Cinemark shares were transferred for no consideration to the Cavalier Revocable Trust. Cavalier and his spouse act as co-trustees, and his immediate family are the sole beneficiaries, so he remains a beneficial owner of the trust-held Cinemark common stock after the transfer.

How many Cinemark (CNK) shares does Michael Cavalier report as indirectly held via trust?

The Form 4 shows 330,681 Cinemark shares held indirectly through the Cavalier Revocable Trust. This indirect holding reflects shares attributed to Cavalier as beneficial owner, with trust governance shared with his spouse and his immediate family as the trust’s sole beneficiaries.

What role does Michael Cavalier hold at Cinemark (CNK) in relation to these Form 4 transactions?

Cavalier serves as Executive Vice President and General Counsel of Cinemark Holdings. The reported equity grants, tax-withholding dispositions, and trust transfer all relate to his position as a senior executive, including performance stock units and restricted shares issued for ongoing and future service to the company.